Advanced technology platforms to define Pharma-CMO relationships for APIs through to 2030

Why are advanced technologies increasingly important for complex small molecule synthesis?

In this whitepaper we outline what the growth in technology platforms used in chemical synthesis means for small, medium and large pharma companies. Selecting a CMO partner is increasingly determined by the size, strength and flexibility of their advanced technology portfolio. This whitepaper will help you assess what you need for large or complex API projects – especially those focusing on large-scale manufacture of HPAPIs.

After reading this whitepaper you will know:

1. Why a combination of chemistries and advanced technologies is crucial for meeting the needs of the pharma industry

2. Why large and complex API projects can only be fulfilled by a small number of CMOs

3. The type and combination of technologies available at Evonik

Download your free whitepaper

Headline H2 - Conditional Container 1

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.